t(1;7;22)(p13;q21;q13) is a novel 3-way variant of t(1;22)(p13;q13) neonatal acute megakaryoblastic leukemia: A case report.

IF 1.4 Q4 ONCOLOGY Molecular and clinical oncology Pub Date : 2023-03-01 DOI:10.3892/mco.2023.2614
Julie Messiaen, Anne Uyttebroeck, Lucienne Michaux, Peter Vandenberghe, Nancy Boeckx, Sandra A Jacobs
{"title":"t(1;7;22)(p13;q21;q13) is a novel 3-way variant of t(1;22)(p13;q13) neonatal acute megakaryoblastic leukemia: A case report.","authors":"Julie Messiaen,&nbsp;Anne Uyttebroeck,&nbsp;Lucienne Michaux,&nbsp;Peter Vandenberghe,&nbsp;Nancy Boeckx,&nbsp;Sandra A Jacobs","doi":"10.3892/mco.2023.2614","DOIUrl":null,"url":null,"abstract":"<p><p>Acute megakaryoblastic leukemia (AMKL) is a rare disease, occurring mostly in infants and young children. The chromosomal translocation t(1;22)(p13;q13), resulting in the RBM15-MKL1 fusion gene, is a recurrent and diagnostic translocation in infants with AMKL. The present case report describes a case of a newborn girl, without Down's syndrome, with congenital AMKL. At birth, the infant had hepatosplenomegaly and the peripheral blood count revealed anemia, thrombopenia and leukocytosis, with 28% blasts. Immunophenotyping demonstrated blasts positive for CD34, CD61 and CD42b. Karyotyping of these blasts (R-banding) showed a hitherto unreported chromosomal translocation, t(1;7;22)(p13;q21;q13), a 3-way variant of the t(1;22)(p13;q13) variant. Fluorescent <i>in situ</i> hybridization analysis confirmed the presence of the RBM15-MKL1 fusion gene.</p>","PeriodicalId":18737,"journal":{"name":"Molecular and clinical oncology","volume":"18 3","pages":"18"},"PeriodicalIF":1.4000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/fe/mco-18-03-02614.PMC9926329.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular and clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3892/mco.2023.2614","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Acute megakaryoblastic leukemia (AMKL) is a rare disease, occurring mostly in infants and young children. The chromosomal translocation t(1;22)(p13;q13), resulting in the RBM15-MKL1 fusion gene, is a recurrent and diagnostic translocation in infants with AMKL. The present case report describes a case of a newborn girl, without Down's syndrome, with congenital AMKL. At birth, the infant had hepatosplenomegaly and the peripheral blood count revealed anemia, thrombopenia and leukocytosis, with 28% blasts. Immunophenotyping demonstrated blasts positive for CD34, CD61 and CD42b. Karyotyping of these blasts (R-banding) showed a hitherto unreported chromosomal translocation, t(1;7;22)(p13;q21;q13), a 3-way variant of the t(1;22)(p13;q13) variant. Fluorescent in situ hybridization analysis confirmed the presence of the RBM15-MKL1 fusion gene.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
t(1;7;22)(p13;q21;q13)是t(1;22)(p13;q13)新生儿急性巨核细胞白血病的一种新的3向变异。
急性巨核母细胞白血病(AMKL)是一种罕见的疾病,多见于婴幼儿。染色体易位t(1;22)(p13;q13)导致RBM15-MKL1融合基因,是AMKL婴儿中一种复发性和诊断性易位。本病例报告描述了一例新生女婴,无唐氏综合征,先天性AMKL。出生时,婴儿肝脾肿大,外周血计数显示贫血、血小板减少和白细胞增多,有28%的细胞。免疫分型显示母细胞CD34、CD61和CD42b阳性。这些细胞的核型(r带)显示了迄今未报道的染色体易位,t(1;7;22)(p13;q21;q13), t(1;22)(p13;q13)变体的三向变体。荧光原位杂交分析证实存在RBM15-MKL1融合基因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
108
期刊最新文献
Bone marrow metastasis of ovarian cancer: A two‑center retrospective study and literature review. Clinical characteristics and predictive factors of pathological lateral pelvic lymph node metastasis in patients with rectal cancer. Cytological features of oncocytic pleomorphic adenoma of the salivary gland: Using the Milan classification system to report 3 patients. Safety study on switching from intravenous to fixed‑dose subcutaneous formulation of pertuzumab and trastuzumab. Ultra‑high dose rate (FLASH) treatment: A novel radiotherapy modality (Review).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1